Get the Stockscreener App
8.89
7.40%
-0.71
After Hours:
8.80
-0.09
-1.01%
Cybin Inc stock is traded at $8.89, with a volume of 454.60K.
It is down -7.40% in the last 24 hours and down -8.26% over the past month.
Cybin Inc., a biotechnology company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Cybin U.S., and Natures Journey. The Serenity Life and Cybin U.S. segment engages in the research and development of psychedelic pharmaceutical products. The Natures Journey segment focuses on non-psychedelic medicinal mushroom nutraceutical products. It develops CYB001, a drug candidate that is in phase IIa/b for major depressive disorder; CYB003, a deuterated tryptamine preclinical program to treat alcohol use disorder; CYB004, a deuterated tryptamine preclinical program for therapy resistant psychiatric disorder; and CYB005, a phenethylamine preclinical program for psychiatry and neurology. The company offers its products through various form factors, such as capsules, powders, and effervescent tablets. Cybin Inc. is headquartered in Toronto, Canada.
See More
Previous Close:
$9.60
Open:
$9.41
24h Volume:
454.60K
Relative Volume:
2.51
Market Cap:
$180.74M
Revenue:
-
Net Income/Loss:
$-52.07M
P/E Ratio:
-45.85
EPS:
-0.1939
Net Cash Flow:
$-44.93M
1W Performance:
-7.68%
1M Performance:
-8.26%
6M Performance:
-43.42%
1Y Performance:
-55.98%
1-Day Range:
$8.80
$9.69
1-Week Range:
$8.80
$10.63
52-Week Range:
$6.50
$28.04
Cybin Inc Stock (CYBN) Company Profile
Name
Cybin Inc
Sector
Industry
Phone
908 764 8385
Address
100 King Street West, Suite 5600, Toronto
Cybin Inc Stock (CYBN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-19-21 | Downgrade | Maxim Group | Buy → Hold |
Cybin Inc Stock (CYBN) Latest News
Cybin (NYSE:CYBN) Shares Gap Down to $9.88 - MarketBeat
Water Tower Research Publishes Initiation of Coverage - GlobeNewswire
Water Tower Research Publishes Initiation of Coverage Report on Cybin, Inc., “A Leader in Novel Neuropsychiatry Therapeutics” - GlobeNewswire Inc.
When the Price of (CYBN) Talks, People Listen - Stock Traders Daily
Cybin Joins Prestigious Neuropsychiatry Summit - TipRanks
Cybin to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit - Business Wire
Ice Cube Says He's 'Never' Been to a Diddy Party After Rapper's Arrest - Us Weekly
Tilray (NASDAQ:TLRY) Shares Down 1.2% - Defense World
Cybin (NYSE:CYBN) Sees Strong Trading Volume - MarketBeat
Cybin (NYSEAMERICAN:CYBN) Sees Strong Trading Volume - Defense World
Cybin (NYSEAMERICAN:CYBN) Sees Unusually-High Trading Volume - MarketBeat
CYBN’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
‘It’s a little kinky’: Diddy shares the key elements of a ‘freak off’ in this old clip - Yahoo Entertainment
Canaccord Genuity Group Lowers Cybin (NYSE:CYBN) Price Target to $96.00 - MarketBeat
Sean ‘Diddy’ Combs Describes His Parties amid ‘Freak Offs’ Allegations in Resurfaced ‘Conan’ Interview: ‘You Need Locks on the Doors’ - Breitbart
Ice Cube Assures Fans He’s Never Been To A Diddy Party Amid “Freak-Off” Accusations - Vibe
Cybin shares target cut by Canaccord, maintains Buy rating - Investing.com
Cybin Inc (CYBN)’s stock chart: A technical perspective - US Post News
Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit - NTB Kommunikasjon
Cybin price target lowered to $96 from $114 at Canaccord - TipRanks
From Usher to Cuba Gooding Jr: Post on alleged Diddy freak off party list of names goes massively viral online - Sportskeeda
Cybin (NYSEAMERICAN:CYBN) Shares Up 7.5% - MarketBeat
Cybin (NYSEAMERICAN:CYBN) Shares Up 7.5% - Defense World
Cybin misses end of summer goal for Phase 3 study start - Green Market Report
Cybin (OTCMKTS:CYBN) Shares Up 4,086.3% - MarketBeat
Cybin Inc. announces share consolidation - Investing.com
Cybin Set to Launch Pivotal Phase 3 Depression Study - TipRanks
Cybin Provides Corporate Update on Upcoming Clinical Milestones - The Bakersfield Californian
Cybin Provides Corporate Update on Upcoming Clinical Milestones - Business Wire
Cybin (NYSEAMERICAN:CYBN) Shares Gap Down to $7.75 - MarketBeat
Cybin Inc. announces share consolidation By Investing.com - Investing.com Australia
Cybin Announces Completion of Previously Announced Share Consolidation - BioSpace
'We're Pretty Cheap At The Moment'Cybin CEO Doug Drysdale (undefined:CYBN) - Seeking Alpha
Cybin Completes Share Consolidation; Maintains Ownership Ratios - TipRanks
Cybin Announces Completion of Previously Announced Share Consolidation - StockTitan
List of influential figures Diddy was allegedly tight with - The Express Tribune
Everything We Know About Diddy’s Alleged ‘Freak Offs’ - The Cut
What Allegedly Happened at Sean ‘Diddy’ Combs’ ‘Freak Off’ Parties - Mandatory
Experts say Diddy's musical legacy is 'pretty much gone,' calling him the 'Bill Cosby of hip-hop' - Fortune
Arizona State Retirement System Boosts Stake in Tilray Inc (NASDAQ:TLRY) - Defense World
Music mogul faces a raft of sex trafficking charges, pleads not guilty - Newstalk ZB
Sean Diddy Combs Indicted on Sex Trafficking and Racketeering Charges Amid Serious Allegations - Oneindia
Upcoming Stock Splits This Week (September 16 to September 20) – Stay Invested - Yahoo Finance
Best Penny Stocks Under $1 To Buy Now - AOL
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) CEO to Participate at the H.C. Wainwright 26th Annual Global Investment Conference - MSN
Cybin Inc. CEO to Speak at Global Investment Conference - TipRanks
Cybin to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - Business Wire
Cybin to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Cybin Inc. (NYSEAMERICAN:CYBN) Short Interest Update - MarketBeat
Cybin (OTCMKTS:CYBN) Trading Down 0.2% - MarketBeat
Cybin Inc. Shareholders Approve Key Decisions - TipRanks
Cybin Inc Stock (CYBN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Cap:
|
Volume (24h):